Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may harm male fertility and damage the reproductive system.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

More than half of patients who had acromegaly surgery experienced hair loss, with varying degrees of recovery.

The document concludes that hair loss in cats is caused by various factors, including allergies, mites, infections, and hormonal issues, with treatments varying accordingly.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Vitamin A deficiency changes cattle hair structure, while pregnancy may improve it, suggesting hair can indicate cattle health.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

The conclusion is that understanding how patterns form in biology is crucial for advancing research and medical science.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

PCOS is caused by both genetics and environmental factors like diet and obesity.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Herbal treatments can help manage PCOS symptoms.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.